Your browser doesn't support javascript.
loading
A perspective on the New American College of Cardiology/American Heart Association guidelines for cardiovascular risk assessment.
Kullo, Iftikhar J; Trejo-Gutierrez, Jorge F; Lopez-Jimenez, Francisco; Thomas, Randal J; Allison, Thomas G; Mulvagh, Sharon L; Arruda-Olson, Adelaide M; Hayes, Sharonne N; Pollak, Amy W; Kopecky, Stephen L; Hurst, R Todd.
Afiliação
  • Kullo IJ; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN. Electronic address: kullo.iftikhar@mayo.edu.
  • Trejo-Gutierrez JF; Division of Cardiovascular Diseases, Mayo Clinic, Jacksonville, FL.
  • Lopez-Jimenez F; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • Thomas RJ; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • Allison TG; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • Mulvagh SL; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • Arruda-Olson AM; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • Hayes SN; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • Pollak AW; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • Kopecky SL; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • Hurst RT; Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, AZ.
Mayo Clin Proc ; 89(9): 1244-56, 2014 Sep.
Article em En | MEDLINE | ID: mdl-25131696
ABSTRACT
The recently published American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for cardiovascular risk assessment provide equations to estimate the 10-year and lifetime atherosclerotic cardiovascular disease (ASCVD) risk in African Americans and non-Hispanic whites, include stroke as an adverse cardiovascular outcome, and emphasize shared decision making. The guidelines provide a valuable framework that can be adapted on the basis of clinical judgment and individual/institutional expertise. In this review, we provide a perspective on the new guidelines, highlighting what is new, what is controversial, and potential adaptations. We recommend obtaining family history of ASCVD at the time of estimating ASCVD risk and consideration of imaging to assess subclinical disease burden in patients at intermediate risk. In addition to the adjuncts for ASCVD risk estimation recommended in the guidelines, measures that may be useful in refining risk estimates include carotid ultrasonography, aortic pulse wave velocity, and serum lipoprotein(a) levels. Finally, we stress the need for research efforts to improve assessment of ASCVD risk given the suboptimal performance of available risk algorithms and suggest potential future directions in this regard.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Guias de Prática Clínica como Assunto Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mayo Clin Proc Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Guias de Prática Clínica como Assunto Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mayo Clin Proc Ano de publicação: 2014 Tipo de documento: Article